| 前收市價 | 40.00 |
| 開市 | 40.00 |
| 買盤 | 42.60 |
| 賣出價 | 51.00 |
| 拍板 | 150.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 40.00 - 40.00 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 4 |
BenzingaWill Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
On Tuesday, Blue Orca Capital released a report on Insulet Corporation (NASDAQ:PODD), saying it is short on the insulin delivery patch pump manufacturer. The report added that Blue Orca is long on its upstart Korean competitor EOFlow Co Ltd as last week the Court of Appeals for the Federal Circuit killed a preliminary injunction that protected Insulet’s key monopoly against competition from EOFlow. The report adds that the injunction is undisclosed to investors. The report notes, “In our opinion
BenzingaWall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York. The latest producer inflation data provided mixed signals ahead of the highly anticipated consumer inflation report on Wednesday. Fed Chair Jerome Powell reiterated his outlook that U.S. monetary policy will maintain its current rate for a longer period than previously anticipated, dismissing fears of new rate hikes. President Joe Biden announced significant tariffs o
ZacksInsulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised
Insulet's (PODD) first-quarter performance benefits from the continued high demand for Omnipod 5.
